Serum type IV collagen in diabetic patients at risk for nephropathyCOHEN, Margo P; SHEARMAN, Clyde W; LAUTENSLAGER, Gregory T et al.Diabetes care. 2001, Vol 24, Num 8, pp 1324-1327, issn 0149-5992Article

Increased Collagen IV excretion in diabetes: A marker of compromised filtration functionCOHEN, Margo P; LAUTENSLAGER, Gregory T; SHEARMAN, Clyde W et al.Diabetes care. 2001, Vol 24, Num 5, pp 914-918, issn 0149-5992Article

Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db miceCOHEN, Margo P; LAUTENSLAGER, Gregory T; SHEARMAN, Clyde W et al.Metabolism, clinical and experimental. 2001, Vol 50, Num 12, pp 1435-1440, issn 0026-0495Article

Glycated albumin stimulates TGF-β1 production and protein kinase C activity in glomerular endothelial cellsCHEN, Sheldon; COHEN, Margo P; LAUTENSLAGER, Gregory T et al.Kidney international. 2001, Vol 59, Num 2, pp 673-681, issn 0085-2538Article

Effects of nonenzymatic glycation and fatty acids on functional properties of human albuminLAUTENSLAGER, Gregory T; SHEARMAN, Clyde W; HUD, Elizabeth et al.Metabolism, clinical and experimental. 2011, Vol 60, Num 12, pp 1683-1691, issn 0026-0495, 9 p.Article

Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathyCOHEN, Margo P; CHEN, Sheldon; ZIYADEH, Fuad N et al.Kidney international. 2005, Vol 68, Num 4, pp 1554-1561, issn 0085-2538, 8 p.Article